Tirzepatide News | Live Feed & Top Stories

Tirzepatide

Fox 819:04Mounjaro Eli Lilly Pharma

KELO TV10:07Mounjaro Eli Lilly Pharma

Pharmaceutical Technology08:57Novo Nordisk Ozempic Pharma

pharmaphorum05:02Novo Nordisk Ozempic Pharma

BBC19:34Mounjaro Ozempic Global Health

ScienceAlert22:36Mounjaro Ozempic Global Health

American Journal of Managed Care09:27Obesity Global Health

Medpage Today16:26Obesity Global Health

Miami Herald19:08Mounjaro FDA Pharma

24/7 Wall St.11:56Mounjaro FDA Pharma

ThePrint15:40Mounjaro Eli Lilly India

KELO TV11:11Mounjaro Eli Lilly India

Clinical Trials Arena07:06Obesity Global Health

Mint08:27Ozempic Novo Nordisk India

News-Medical.Net21:38Cancer Treatment Health Insulin

Pharmaceutical Technology09:13Cancer Treatment Health Insulin

Bloomberg Law13:57FDA Mounjaro Health

Latest News

In the last 4 hours

ThePrint23:49 10-Mar-25

ScienceAlert22:36 10-Mar-25

In the last 6 hours

Entrepreneur Magazine21:01 10-Mar-25

In the last 8 hours

BBC19:34 10-Mar-25

Fox 819:04 10-Mar-25

PR Newswire (Press Release)18:21 10-Mar-25

Yesterday

KELO TV16:37 10-Mar-25

ThePrint15:40 10-Mar-25

Bloomberg Law13:57 10-Mar-25

The Motley Fool13:06 10-Mar-25

ENDPOINTS12:57 10-Mar-25

PR Newswire (Press Release)11:34 10-Mar-25

KELO TV11:11 10-Mar-25

Yahoo! UK & Ireland10:29 10-Mar-25

Yahoo! US10:25 10-Mar-25

GlobeNewswire (Press Release)09:21 10-Mar-25

pharmaphorum08:21 10-Mar-25

The Economic Times06:38 10-Mar-25

GlobeNewswire (Press Release)06:29 10-Mar-25

In the last 7 days

News-Medical.Net21:38 9-Mar-25

The Times of India20:22 9-Mar-25

MailOnline05:39 9-Mar-25

BBC19:27 8-Mar-25

MailOnline15:06 8-Mar-25

JD Supra15:07 7-Mar-25

British Medical Journal12:23 7-Mar-25

Medpage Today09:40 7-Mar-25

Kaiser Health News09:19 7-Mar-25

FiercePharma08:56 7-Mar-25

Miami Herald19:08 6-Mar-25

ABC Online17:05 6-Mar-25

The Motley Fool12:24 6-Mar-25

Health Magazine11:43 6-Mar-25

Business Weekly10:38 6-Mar-25

Pharmaceutical Technology08:57 6-Mar-25

Business Wire (Press Release)08:51 6-Mar-25

GlobeNewswire (Press Release)08:34 6-Mar-25

Mint08:27 6-Mar-25

GlobeNewswire (Press Release)08:05 6-Mar-25

Zacks08:05 6-Mar-25

pharmaphorum05:02 6-Mar-25

Medpage Today16:26 5-Mar-25

Fox News13:05 5-Mar-25

Yahoo! US11:04 5-Mar-25

KELO TV10:07 5-Mar-25

PoliticsHome09:41 5-Mar-25

WNEM09:28 5-Mar-25

American Journal of Managed Care09:27 5-Mar-25

PR Newswire (Press Release)08:44 5-Mar-25

Zacks08:30 5-Mar-25

Clinical Trials Arena07:06 5-Mar-25

The Motley Fool04:42 5-Mar-25

Korea Biomedical Review19:41 4-Mar-25

Medpage Today16:41 4-Mar-25

PR Newswire (Press Release)15:54 4-Mar-25

Scientific American09:49 4-Mar-25

pharmaphorum05:05 4-Mar-25

Indian Express00:02 4-Mar-25

In the last month

Channel NewsAsia17:09 3-Mar-25

GlobeNewswire (Press Release)16:07 3-Mar-25

IOL12:09 3-Mar-25

Tyla11:37 3-Mar-25

Pharmaceutical Technology07:13 3-Mar-25

MailOnline06:46 3-Mar-25

pharmaphorum05:00 3-Mar-25

The Motley Fool15:41 2-Mar-25

Nature.com13:19 1-Mar-25

MailOnline13:14 1-Mar-25

The Columbian, Washington09:04 1-Mar-25

Rock Hill Herald17:42 28-Feb-25

KELO TV11:20 28-Feb-25

Behavioural and Social Sciences at Nature Research06:41 28-Feb-25

PR Newswire (Press Release)06:04 28-Feb-25

British Medical Journal05:48 28-Feb-25

MailOnline02:58 28-Feb-25

People21:30 27-Feb-25

Irish Examiner20:06 27-Feb-25

Drug Topics17:02 27-Feb-25

Pharmacy Times15:45 27-Feb-25

GlobeNewswire (Press Release)13:04 27-Feb-25

The Good Men Project12:38 27-Feb-25

GlobeNewswire (Press Release)08:07 27-Feb-25

Business Wire (Press Release)07:03 27-Feb-25

film-news.co.uk04:11 27-Feb-25

British Medical Journal18:52 26-Feb-25

TCTMD18:33 26-Feb-25

Medpage Today18:30 26-Feb-25

Forbes12:06 26-Feb-25

Pharmacy Times12:00 26-Feb-25

FOX13 Seattle11:45 26-Feb-25

PRWeb (Press Release)08:20 26-Feb-25

The Motley Fool04:24 26-Feb-25

Gazette News01:46 26-Feb-25

Forbes21:11 25-Feb-25

Scrip Pharma Intelligence18:08 25-Feb-25

Quartz17:45 25-Feb-25

Medpage Today17:14 25-Feb-25

The Conversation (UK)15:47 25-Feb-25

Medpage Today15:01 25-Feb-25

The Conversation (AU)14:38 25-Feb-25

The Motley Fool12:38 25-Feb-25

British Medical Journal10:46 25-Feb-25

Daily Record09:36 25-Feb-25

PR Newswire (Press Release)09:03 25-Feb-25

Forbes09:00 25-Feb-25

pharmaphorum07:50 25-Feb-25

Business Wire (Press Release)07:37 25-Feb-25

PR Newswire (Press Release)06:50 25-Feb-25

i News05:27 25-Feb-25

Yahoo! UK & Ireland05:06 25-Feb-25

Women's Health UK04:26 25-Feb-25

The Financial Express16:50 24-Feb-25

24/7 Wall St.13:18 24-Feb-25

GlobeNewswire (Press Release)13:08 24-Feb-25

PR Newswire (Press Release)11:01 24-Feb-25

view more headlines

10 Mar 23:49

About our Tirzepatide news

Latest news on Tirzepatide, a drug that is being developed as a potential treatment for obesity and type 2 diabetes. It is a synthetic hormone that is designed to mimic the effects of natural hormones called incretins, which help to lower blood sugar and reduce appetite. Tirzepatide has shown promise in clinical trials, producing significant weight loss in people with obesity or type 2 diabetes. It is administered as a once-weekly injection, and it is believed to work by increasing the production of a hormone called GLP-1, which helps to regulate appetite and insulin production. Tirzepatide is currently in late-stage clinical trials, and it is expected to be considered for regulatory approval in the coming years.

쮸떴눈첵

Tirzepatide

Latest News

About our Tirzepatide news

Health Top Stories

Lifestyle Top Stories